Global Oxiracetam Injection Market Size, Share, and Trends Analysis Report, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), Forecast (2022-2028)

The global oxiracetam injection market is anticipated to grow at a CAGR of 4.0% during the forecast period (2022- 2028). Oxiracetam is a nootropic drug of the racetam family and a very mild stimulant. It is one of the brain-booster and most popular nootropics. It is used to treat cognitive deficits of cerebrovascular origins and has mild stimulant capability. The nootropic drug is well-known for its ability to boost mental energy, cognition, and memory. It is available in the form of injections and capsules. The injection form is widely used for stroke patients whose memories were affected, while the oral form is used for patients with Alzheimer’s disease. The rise in demand for brain boosters and high consumer awareness about brain health and also the rise in Alzheimer’s disease, dementia, and other neurological problems are the factors that boost the growth of the market. Factors such as the increasing aging population, alcohol and drug abuse, and other trauma resulting in short memory are propelling the demand for the oxiracetam injection. Side effects such as elevated blood pressure due to hypertension restrain the growth of the market.

Some major companies in the market include Haerbin Medisan Pharmaceutical Co Ltd, CSPC Pharmaceutical Group Ltd, and Guangdong Shixin Pharmaceutical Co. Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships, new product launches, and collaborations, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By  Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– HaerbinMedisan Pharmaceutical Co Ltd., CSPC Pharmaceutical Group Ltd., and Guangdong Shixin Pharmaceutical Co. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?

Global Oxiracetam Injection Market Report by Segment

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Oxiracetam Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa